HCW Biologics enters agreement to sell promissory notes to Streeterville Capital
HCW Biologics Inc. signed a Notes Purchase Agreement dated October 2026 with Streeterville Capital, LLC, to sell promissory notes for a total purchase price of $10 million.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed